Neurodegenerative diseases (NDs), such as Parkinson’s Disease (PD), Alzheimer’s (AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS), are characterized by progressive loss of structure or function neurons. Current therapies for NDs only symptomatic long-term ineffective. This challenge has promoted the development new against relevant targets in these pathologies. In this revie...